Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes

Bo Deng,Yue Ma,Jialyu Huang,Runbang He,Miaomiao Luo,Lina Mao,Enhua Zhang,Yuanyuan Zhao,Xiaoli Wang,Qiangsong Wang,Mingchang Pang,Yilei Mao,Huayu Yang,Lanxia Liu,Pengyu Huang

DOI: https://doi.org/10.1126/sciadv.ado1550

IF: 13.6

2024-06-09

Science Advances

Abstract:The utilization of three-dimensional (3D) bioprinting technology to create a transplantable bioartificial liver emerges as a promising remedy for the scarcity of liver donors. This study outlines our strategy for constructing a 3D-bioprinted liver, using in vitro–expanded primary hepatocytes recognized for their safety and enhanced functional robustness as hepatic cell sources for bioartificial liver construction. In addition, we have developed bioink biomaterials with mechanical and rheological properties, as well as printing capabilities, tailored for 3D bioprinting. Upon heterotopic transplantation into the mesentery of tyrosinemia or 90% hepatectomy mice, our 3D-bioprinted liver effectively restored lost liver functions, consequently extending the life span of mice afflicted with liver injuries. Notably, the inclusion of an artificial blood vessel in our 3D-bioprinted liver allowed for biomolecule exchange with host blood vessels, demonstrating, in principle, the rapid integration of the bioartificial liver into the host vascular system. This model underscores the therapeutic potential of transplantation for the treatment of liver failure diseases.

multidisciplinary sciences

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is the shortage of donor livers in the treatment of liver failure. Specifically, the researchers used three - dimensional (3D) bioprinting technology, combined with in - vivo - expanded primary hepatocytes (eHep cells), to construct a transplantable bio - artificial liver (3DP - liver). This bio - artificial liver has demonstrated the ability to restore the function of damaged livers in a mouse model, thereby prolonging the lifespan of mice with liver damage. In addition, the study also explored the possibility of rapid integration of the bio - artificial liver with the host vascular system in vivo, which provides theoretical basis and technical support for further application in the treatment of human liver failure diseases.

The key points of the study include:
1. **Development of 3D bioprinting materials**: The researchers developed a bio - ink (3D - DLS gel) containing gelatin, sodium alginate and decellularized liver matrix (LDCM) for 3D bioprinting.
2. **In - vitro expansion of primary hepatocytes**: Continuous passage of primary hepatocytes was achieved through a specific medium (HEM), maintaining their key liver functions.
3. **Functional evaluation of 3DP - liver**: In - vitro experiments showed that 3DP - liver can express multiple liver - function - related genes and has functions such as glycogen storage, indocyanine green (ICG) absorption / release, and acetylated low - density lipoprotein (ac - LDL) uptake.
4. **In - vivo transplantation of 3DP - liver**: In mouse models of tyrosinemia or 90% hepatectomy, 3DP - liver can quickly establish connections with the host vascular system, restore liver function, and significantly prolong the survival period of mice.

These results indicate that 3D bioprinting technology combined with in - vivo - expanded primary hepatocytes provides a new and potentially promising solution to the problem of donor shortage in the treatment of liver failure.